Prucalopride (Motegrity) for Chronic Idiopathic Constipation
Date: June 3, 2019
Issue #:
1573Summary:
The FDA has approved the 5-HT4 receptor agonist
prucalopride (Motegrity– Shire) for treatment of chronic
idiopathic constipation (CIC) in adults. Prucalopride is
the only drug currently approved in the US for treatment
of CIC that stimulates colonic peristalsis. It has been
available in Europe and Canada for several years.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: amitiza Bisacodyl Constella Constipation dulcolax linaclotide Linzess lubiprostone Miralax Motegrity plecanatide Polyethylene Glycol prucalopride Resotran Restoralax Tegaserod Trulance Zelnorm Source Type: research